To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.
Patients aged 2 to 60 years.
Patients undergoing EM procedures requiring sedation.
Patients with contraindications to any of the sedation agents being studied.
Patients with a history of adverse reactions or allergies to the study medications.
Drug interactions: Patients taking certain medications that may interact adversely with the study medications.
Drug Abuser